[Federal Register Volume 88, Number 179 (Monday, September 18, 2023)]
[Notices]
[Page 63968]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-20105]
[[Page 63968]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Rational Systematic
Characterization and Selection of Adjuvants for HIV Vaccine
Candidates (R-CASA).
Date: October 10, 2023.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Rockville, MD
20892 (Virtual Meeting).
Contact Person: Stephen Anthony Gallo, Ph.D., Scientific Review
Officer, Scientific Review Program, National Institute of Allergy
and Infectious Diseases, National Institutes of Health, 5601 Fishers
Lane, MSC-9823, Rockville, MD 20852, (240) 669-2858,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: September 12, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-20105 Filed 9-15-23; 8:45 am]
BILLING CODE 4140-01-P